Loblaw, CA5394811015

Loblaw stock: Shoppers Drug Mart sells QHR Technologies

Published on 11/18/2026 at 16:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Loblaw stock: Shoppers Drug Mart sold QHR Technologies to LGI Healthcare Solutions on November 18. The companies will continue working together.

Healthcare software sale reshapes focus

  • Shoppers Drug Mart sold QHR Technologies to LGI Healthcare Solutions while retaining a commercial and strategic relationship.
  • QHR's Accuro platform connects Canadian healthcare providers, patients and clinics.
  • Loblaw is due to release third-quarter 2026 results on November 19.
Loblaw, CA5394811015, Illustration mit AI erstellt.

Loblaw stock: Shoppers Drug Mart sold QHR Technologies to LGI Healthcare Solutions on Wednesday, November 18, while preserving a commercial and strategic relationship with the Canadian healthcare software company. MarketScreener carried the company release, which said the transaction is intended to support continued growth and innovation in Canadian healthcare while maintaining Canadian ownership.

Healthcare software changes hands

QHR develops digital-health software and operates Accuro, an electronic medical-record platform with clinic-management and patient-engagement tools. The release describes Accuro as the largest single-platform electronic medical-record system in Canada.

Gregers Wedell-Wedellsborg, president of Shoppers Drug Mart, said QHR and LGI would begin a new phase of growth while continuing their relationship with Shoppers. The announcement places the transaction within Loblaw's broader pharmacy and healthcare activities, alongside Shoppers' retail drug stores, medical clinic pharmacies and related health services.

MarketScreener's report said TD Securities acted as exclusive financial adviser to Shoppers Drug Mart and McCarthy Tétrault provided legal counsel.

Results remain the next catalyst

Loblaw's third-quarter 2026 results are scheduled for Thursday, November 19, according to the company calendar carried on the same MarketScreener page. The earnings release will give investors the next broad read on food retail, pharmacy and the group's wider growth initiatives.

Loblaw stock traded at 45.20 euros on Lang & Schwarz at 16:11 CET on Wednesday, November 18.

Loblaw Companies at a glance

  • Company: Loblaw Companies Limited
  • ISIN: CA5394811015
  • Trading symbol: L
  • Primary listing: Toronto Stock Exchange
  • Quoted price: 45.20 euros on Lang & Schwarz at 16:11 CET, Wednesday, November 18, 2026
  • Sector: Food Retail & Distribution

Canada's broader market context is covered in Current market reports.

More news and analyses on Loblaw stock

Disclaimer...
en | CA5394811015 | LOBLAW | boerse | 70531501 | bgmi